Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Conference News AHA 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

Todd Neale

November 13, 2025

News Daily News

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Michael O'Riordan

July 18, 2023

News Daily News

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Yael L. Maxwell

November 21, 2022

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

News Daily News

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Michael O'Riordan

November 03, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Todd Neale

September 03, 2019

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

News Daily News

Prior PCI Does Not Affect Early CABG Outcomes: Registry and Meta-analysis

Leah Lawrence

February 16, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Todd Neale

June 22, 2015

News Daily News

Study Finds No ‘Obesity Paradox’ in DES-Treated Patients

Jason Kahn

March 06, 2012

News Daily News

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Jason Kahn

March 06, 2012

Advertisement

Frail Patients Stand to Gain Most From Cardiac Rehab

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

More Angina Relief With Complete Revascularization in Stable CAD: ISCHEMIA

Single-Center Study Offers Insights for Ticagrelor vs Prasugrel in Chronic CAD

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Fewer MIs With Prasugrel Than Ticagrelor in STEMI Patients: ISAR-REACT 5

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Prior PCI Does Not Affect Early CABG Outcomes: Registry and Meta-analysis

TCTMD’s Top 10 Most Popular Stories for December 2017

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

Method Chosen to Estimate Pre-PCI Kidney Function Matters

ACCOAST Analysis Identifies Factors Tied to Higher Bleeding Risks in NSTE-ACS

Study Finds No ‘Obesity Paradox’ in DES-Treated Patients

It’s DESTINY: DES Superior to BMS for Below-the-Knee Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content